These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7693512)

  • 1. Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo.
    Rutishauser J; Schmid C; Hauri C; Froesch ER; Zapf J
    FEBS Lett; 1993 Nov; 334(1):23-6. PubMed ID: 7693512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
    Gargosky SE; Nanto-Salonen K; Tapanainen P; Rosenfeld RG
    J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity.
    Fielder PJ; Thordarson G; Talamantes F; Rosenfeld RG
    Endocrinology; 1990 Nov; 127(5):2270-80. PubMed ID: 1699743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.
    Zapf J; Hauri C; Waldvogel M; Futo E; Häsler H; Binz K; Guler HP; Schmid C; Froesch ER
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3813-7. PubMed ID: 2471192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of pituitary regulation of growth in the developing rat: comparison of effects of hypophysectomy and hormone replacement on somatic and organ growth, serum insulin-like growth factor-I (IGF-I) and IGF-II levels, and IGF-binding protein levels in the neonatal and juvenile rat.
    Glasscock GF; Gin KK; Kim JD; Hintz RL; Rosenfeld RG
    Endocrinology; 1991 Feb; 128(2):1036-47. PubMed ID: 1703478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone.
    Gosteli-Peter MA; Winterhalter KH; Schmid C; Froesch ER; Zapf J
    Endocrinology; 1994 Dec; 135(6):2558-67. PubMed ID: 7527334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum.
    Clemmons DR; Thissen JP; Maes M; Ketelslegers JM; Underwood LE
    Endocrinology; 1989 Dec; 125(6):2967-72. PubMed ID: 2479531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.
    van Buul-Offers SC; Bloemen RJ; Reijnen-Gresnigt MG; van Leiden HA; Hoogerbrugge CM; Van den Brande JL
    J Endocrinol; 1994 Oct; 143(1):191-8. PubMed ID: 7525829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue.
    Peter MA; Winterhalter KH; Böni-Schnetzler M; Froesch ER; Zapf J
    Endocrinology; 1993 Dec; 133(6):2624-31. PubMed ID: 7694843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of the insulin-like growth factors (IGFs) in the hypophysectomized rat: comparison with human growth hormone and the possible role of the specific IGF carrier proteins.
    Zapf J; Schoenle E; Froesch ER
    Ciba Found Symp; 1985; 116():169-87. PubMed ID: 2416518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
    Young SC; Underwood LE; Celniker A; Clemmons DR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
    Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG
    Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts.
    Fowlkes J; Freemark M
    Endocrinology; 1992 Nov; 131(5):2071-6. PubMed ID: 1385096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
    Lalou C; Silve C; Rosato R; Segovia B; Binoux M
    Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Several insulin-like growth factor-I analogues and complexes of insulin-like growth factors-I and -II with insulin-like growth factor-binding protein-3 fail to mimic the effect of growth hormone upon lactation in the rat.
    Flint DJ; Tonner E; Beattie J; Gardner M
    J Endocrinol; 1994 Feb; 140(2):211-6. PubMed ID: 7513341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.
    Zapf J; Schmid C; Guler HP; Waldvogel M; Hauri C; Futo E; Hossenlopp P; Binoux M; Froesch ER
    J Clin Invest; 1990 Sep; 86(3):952-61. PubMed ID: 1697608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.